The emerging treatment of the medication represents a significant development in the management of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide482938.eedblog.com/42293374/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment